Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 6, 2012, Pages 895-904

  Shapiro, Jean A ^a   Klabunde, Carrie N ^b   Thompson, Trevor D ^a   Nadel, Marion R ^a   Seeff, Laura C ^a   White, Arica ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; EDUCATION; FEMALE; HEALTH CARE; HEALTH CARE ACCESS; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; INCOME; MALE; OCCULT BLOOD TEST; PREVALENCE; PRIORITY JOURNAL; SCREENING TEST; SIGMOIDOSCOPY;

AGED; COLONOGRAPHY, COMPUTED TOMOGRAPHIC; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; UNITED STATES;

EID: 84862859235     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-0192     Document Type: Article

References (40)

1. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008;149:627-37.
2. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecaloccult-blood test. Lancet 1996;348:1467-71. (Pubitemid 26400241)
3. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecaloccult-blood screening for colorectal cancer. Lancet 1996;348:1472-7. (Pubitemid 26400242)
4. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7.
5. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84:1572-5.
6. Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med 1995;123:904-10.
7. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-71. (Pubitemid 23131388)
8. McFarland EG, Levin B, Lieberman DA, Pickhardt PJ, Johnson CD, Glick SN, et al. Revised colorectal screening guidelines: joint effort of the American Cancer Society, U.S. Multisociety Task Force on Colorectal Cancer, and American College of Radiology. Radiology 2008;248:717-20.
9. Johnson CD, Chen MH, Toledano AY, Heiken JP, Dachman A, Kuo MD, et al. Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med 2008;359:1207-17.
10. Stoop EM, de Haan MC, de Wijkerslooth TR, Bossuyt PM, van Ballegooijen M, Nio CY, et al. Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Lancet Oncol 2012;13:55-64.
11. Klabunde CN, Cronin KA, Breen N, Waldron WR, Ambs AH, Nadel MR. Trends in colorectal cancer test use among vulnerable populations in the United States. Cancer Epidemiol Biomarkers Prev 2011;20:1611-21.
12. Shapiro JA, Seeff LC, Thompson TD, Nadel MR, Klabunde CN, Vernon SW. Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 2008;17:1623-30.
13. National Center for Health Statistics. Data file documentation, National Health Interview Survey, 2010 (machine readable data file and documentation). Hyattsville, MD: National Center for Health Statistics, Centers for Disease Control and Prevention; 2011.
14. Hall HI, Van Den Eeden SK, Tolsma DD, Rardin K, Thompson T, Hughes Sinclair A, et al. Testing for prostate and colorectal cancer: comparison of self-report and medical record audit. Prev Med 2004;39:27-35. (Pubitemid 38797953)
15. Schenker N, Raghunathan TE, Chiu P, Makuc DM, Zhang G, Cohen AJ. Multiple imputation of family income and personal earnings in the National Health Interview Survey: methods and examples. Hyattsville, MD: National Center for Health Statistics; 2008 [cited 2011 Aug 24]. Available from: http://www.cdc.gov/nchs/data/nhis/tecdoc.pdf.
16. Graubard BI, Korn EL. Predictive margins with survey data. Biometrics 1999;55:652-9. (Pubitemid 29302598)
17. Breslow NE, Day NE. Statistical methods in cancer research. Volume II. The design and analysis of cohort studies. Lyon, France: IARC Sci Publ; 1987.
18. Centers for Disease Control and Prevention. Cancer screening - United States, 2010. MMWR Morb Mortal Wkly Rep 2012;61:41-5.
19. Nadel MR, Blackman DK, Shapiro JA, Seeff LC. Are people being screened for colorectal cancer as recommended? Results from the National Health Interview Survey. Prev Med 2002;35:199-206.
20. Swan J, Breen N, Graubard BI, McNeel TS, Blackman D, Tangka FK, et al. Data and trends in cancer screening in the United States: results from the 2005 National Health Interview Survey. Cancer 2010;116:4872-81.
21. Centers for Disease Control and Prevention (CDC). Vital signs: colorectal cancer screening, incidence, and mortality-United States, 2002-2010. MMWR Morb Mortal Wkly Rep 2011;60:884-9.
22. Seeff LC, Nadel MR, Klabunde CN, Thompson T, Shapiro JA, Vernon SW, et al. Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer 2004;100:2093-103. (Pubitemid 38580326)
23. May DS, Trontell AE. Mammography use by elderly women: a methodological comparison of two national data sources. Ann Epidemiol 1998;8:439-44. (Pubitemid 28411385)
24. Ackermann SP, Brackbill RM, Bewerse BA, Cheal NE, Sanderson LM. Cancer screening behaviors among U.S. women: breast cancer, 1987-1989, and cervical cancer, 1988-1989. MMWR CDC Surveill Summ 1992;41:17-25.
25. Chao HH, Schwartz AR, Hersh J, Hunnibell L, Jackson GL, Provenzale DT, et al. Improving colorectal cancer screening and care in the Veterans Affairs Healthcare system. Clin Colorectal Cancer 2009;8:22-8.
26. Department of Veterans Affairs. VHA Directive 2007-004. Colorectal cancer screening. Washington, DC; 2007 [cited 2011 Nov 29]. Available from: http://www1.va.gov/vhapublications/ViewPublication.asp?pub-ID=1530
27. Collins JF, Lieberman DA, Durbin TE, Weiss DG. Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice. Ann Intern Med 2005;142:81-5.
28. U.S. Preventive Services Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med 2002;137:129-31.
29. Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology 2003;124:544-60. (Pubitemid 36169269)
30. Centers for Medicare and Medicaid Services. Colorectal cancer: preventable, treatable, and beatable - Medicare coverage and billing for colorectal cancer screening. Medicare Learning Network Matters Baltimore, MD; 2007 [cited 2011 Dec 13]. Available from: www.cms.hhs.gov/MLNMattersArticles/ downloads/SE0710.pdf.
31. Nadel MR, Berkowitz Z, Klabunde CN, Smith RA, Coughlin SS, White MC. Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious deviations from evidence-based recommendations. J Gen Intern Med 2010;25:833-9.
32. Nadel MR, Shapiro JA, Klabunde CN, Seeff LC, Uhler R, Smith RA, et al. A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med 2005;142:86-94
33. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2008;149:659-69.
34. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating test strategies for colorectal cancer screening - age to begin, age to stop, and timing of screening intervals: a decision analysis of colorectal cancer screening for the U.S. Preventive Services Task Force from the Cancer Intervention and Surveillance Modeling Network (CISNET). Evidence Synthesis No. 65, Part 2. Rockville, MD: Agency for Healthcare Research and Quality; 2009.
35. Khoja S, McGregor SE, Hilsden RJ. Validation of self-reported history of colorectal cancer screening. Can Fam Physician 2007;53:1192-7. (Pubitemid 47236005)
36. Shokar NK, Vernon SW, Carlson CA. Validity of self-reported colorectal cancer test use in different racial/ethnic groups. Fam Pract 2011;28:683-8.
37. Partin MR, Grill J, Noorbaloochi S, Powell AA, Burgess DJ, Vernon SW, et al. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans. Cancer Epidemiol Biomarkers Prev 2008;17:768-76. (Pubitemid 351536404)
38. Vernon SW, Tiro JA, Vojvodic RW, Coan S, Diamond PM, Greisinger A, et al. Reliability and validity of a questionnaire to measure colorectal cancer screening behaviors: does mode of survey administration matter? Cancer Epidemiol Biomarkers Prev 2008;17:758-67. (Pubitemid 351536403)
39. Jones RM, Mongin SJ, Lazovich D, Church TR, Yeazel MW. Validity of four self-reported colorectal cancer screening modalities in a general population: differences over time and by intervention assignment. Cancer Epidemiol Biomarkers Prev 2008;17:777-84. (Pubitemid 351536405)
40. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999-2007 incidence and mortality web-based report. Atlanta, GA; 2010 [cited 2011 Dec 1]. Available from: www.cdc.gov/uscs.